Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Novo Nordisk
 More »

  • Novo Nordisk Reports Promising Phase III Results for Hemophilia...
    Novo Nordisk today reported positive results from its paradigm(tm)2 Phase III trial for N9-GP (glycopegylated recombinant factor IX), for hemophilia B patients. The multi-center ...
    5-17-2013
  • Emergent, Caisson Collaborating to Optimize Heparosan Drug Delivery...
    Emergent said that planning for this partnership was a year in the making, after Caisson signed a development and licensing deal worth up to $100 million with Novo Nordisk . ...
    5-1-2013
  • Genome Editing for R&D and Therapeutics
    ... They are also pursuing diabetes in collaboration with Novo Nordisk. "There is a huge market for companies wanting to model their test drugs. We are also utilizing our TALEN ...
    3-1-2013
  • Growing the Biobased Economy
    Not a single industrial biotech company was publicly traded. Novozymes was still to be spun out of Novo Nordisk. Dow Chemical was the most heavily and widely invested strategic ...
    2-21-2013
  • FDA Blocks Novo, Boosts Celgene
    FDA delivered bad news to Novo Nordisk and good news to Celgene in separate decisions Friday on applications for marketing new drugs. The agency threw a curve to Novo by insisting ...
    2-11-2013
  • Challenging the Limits of Protein Characterization
    ... They tell you basically what to do, but they don't tell you how to do it, nor when to do it, nor propose clear acceptance criteria." Where Is It? Researchers at Novo Nordisk use ...
    2-1-2013
  • Type 2 Diabetes Drugs Drive Sector Growth
    ... Novo Nordisk, one of the biggest suppliers of insulin, submitted an NDA in November for Tresiba® (degludec), which offers extended dosing but increases cardiovascular risks. ...
    2-1-2013
  • Novo Nordisk Diabetes Drugs Green-Lighted by EC
    The European Commission today granted Novo Nordisk approval across all 27 European Union member states for two new adult diabetes drugs-Tresiba® (insulin degludec) and Ryzodeg® ...
    1-22-2013
  • Eliminating Biological Change after Excision
    ... However, in a study by Professor Jesper Olsen's research group at the Center for Protein Research, Novo Nordisk Foundation, heat stabilization has been incorporated into their ...
    1-15-2013
  • Adimab Inks Double Deals with Merck & Lilly
    Over the past three years, Adimab has established collaborations with Merck, Roche, Novartis, Pfizer, Eli Lilly, Genentech, Biogen Idec, Novo Nordisk, Gilead, and Kyowa Hakko ...
    1-8-2013
  • 25 Diabetes Drugs in the Pipeline Right Now
    ... expected to be filed in first half of 2013) IDegLira (NN9068) Sponsor/Developer: Novo Nordisk Mechanism of action: Combination of Tresiba® (insulin degludec) and Victoza® ...
    11-30-2012
  • Novo Nordisk Drops Phase III Hemophilia Drug
    Novo Nordisk has confirmed it will drop further development of the hemophilia therapy candidate vareptacog alfa, as a consequence of reports in August that some patients in a Phase ...
    10-1-2012
  • BAC Targeting Biosimilar Market
    of blood coagulants by BAC, which is based in The Netherlands. "NovoSeven® RT (Novo Nordisk's coagulation Factor VIIa recombinant) will be going off patent soon, thus ...
    9-4-2012
  • Top 25 Biotech Companies
    ... Cap: $49.72 billion (7/27: 924,091,356 shares * price $53.80) % Change: 20.9% #1. Novo Nordisk 2012 Market Cap: $76.92 billion (6/30: DKK 549.1 million * price DKK 848.50) 2011 ...
    8-17-2012
  • Battles Over FDA Use Code Challenge Branded Drug Exclusivity
    Two recent Federal Circuit decisions, Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd. (2012) and AstraZeneca Pharmaceuticals LP v. Apotex Corp. , 669 F.3d 1370 (2012), ...
    8-7-2012
  • More »

    Journal Articles

  • Effect of Different Hydrolysates of Whey Protein on Hepatic Glutathion...
    Maria Teresa Bertoldo Pacheco, Valdemiro Carlos Sgarbieri
    Journal of Medicinal Food
    This study was designed to compare the effects of diets prepared with enzymatic hydrolysate of a whey protein concentrate (WPC) by pancreatin, protamex(tm) (Novo Nordisk, ...
  • Antioxidant Activity of Enzymatic Extracts from Stellaria dichotoma
    Beong Ou Lim, Soung-Hee Choi, Eun-Kyung Kim, Seung-Jae Lee, Jae-Young Je, You-Jin Jeon, BoKyung Kim, Seung Hwa Park, Sang-Ho Moon, Byong-Tae Jeon, Kwang-Ho Lee, Tae-Kyu Park, Pyo-Jam Park
    Journal of Medicinal Food
    Flavourzyme®, Neutrase®, pancreatic trypsin, and Alcalase®) (all from Novo Co., Novozyme Nordisk, Bagsvaerd, Denmark) for 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical, ...
  • Needle with a Novel Attachment Versus Conventional Screw-Thread...
    Birtha Hansen, Søren K. Lilleøre, Gitte Ter-Borch
    Diabetes Technology & Therapeutics
    Diabetes Technology & Therapeutics Abstract Background: NovoTwist® (Novo Nordisk A/S, Bagsværd, Denmark) is an insulin pen needle that features a novel attachment and detachment ...
  • Study on the Dosing Accuracy of Commonly Used Disposable Insulin...
    Meike Krzywon, Thomas van der Burg, Uwe Fuhr, Manfred Schubert-Zsilavecz, Mona Abdel-Tawab
    Diabetes Technology & Therapeutics
    Materials and Methods: In total, 15 previously unused insulin pens from two lots of each pen type (SoloSTAR® [sanofi-aventis, Paris, France], FlexPen® [Novo Nordisk A/S, ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll